Rhodococcus Equi: Challenges to Treat Infections and to Mitigate Antimicrobial Resistance

Rare case of Rhodococcus hoagii bacteremia in an HIV late‑presenter with NTM pulmonary disease: A case report and review of the literature

“…To the best of our knowledge, to date, no standardized therapy has yet been established for the treatment of R. hoagii infections, and there are no defined susceptibility interpretation criteria for R. hoagii in the guidelines provided by the Clinical and Laboratory Standards Institute (CLSI) or the European Committee on Antimicrobial Susceptibility Testing (EUCAST) (27). Consequently, susceptibility assessments for R. hoagii are frequently based on extrapolations from other species and pathogens, such as Staphylococcus aureus (28).…”

“…For humans, particularly those in contact with farm animals, proper wound care and hygiene practices are crucial. Public health interventions may include educational campaigns to raise awareness about the risks and transmission routes of R. hoagii and promoting the use of protective equipment for farm workers (27,36).…”